Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 5 de 5
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
PLoS One ; 11(2): e0136709, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-26914483

RESUMEN

BACKGROUND: One of the largest cross-sectional study in recent years was carried out to investigate the prevalence of intestinal parasitic infections among urban and rural school children from five states namely Selangor, Perak, Pahang, Kedah and Johor in Peninsula Malaysia. This information would be vital for school authorities to influence strategies for providing better health especially in terms of reducing intestinal parasitism. METHODS AND PRINCIPAL FINDINGS: A total of 3776 stool cups was distributed to 26 schools throughout the country. 1760 (46.61%) responded. The overall prevalence of intestinal parasitic infection in both rural and urban areas was 13.3%, with Blastocystis sp (10.6%) being the most predominant, followed by Trichuris trichiura (3.4%), Ascaris lumbricoides (1.5%) and hook worm infection (0.9%). Only rural school children had helminthic infection. In general Perak had the highest infection (37.2%, total, n = 317), followed by Selangor (10.4%, total, n = 729), Pahang (8.6%, total, n = 221), Kedah (6.2%, total, n = 195) and Johor (3.4%, total, n = 298). School children from rural schools had higher infection (13.7%, total, n = 922) than urban school children (7.2%, total, n = 838). Subtype (ST) 3 (54.3%) is the most predominant ST with persons infected with only ST1 and ST3 showing symptoms. Blastocystis sp infection significantly associated with low household income, low parent's education and presence of symptoms (p<0.05). CONCLUSION: It is critical that we institute deworming and treatment to eradicate the parasite especially in rural school children.


Asunto(s)
Infecciones por Blastocystis/epidemiología , Blastocystis/clasificación , Blastocystis/genética , Blastocystis/aislamiento & purificación , Infecciones por Blastocystis/parasitología , Infecciones por Blastocystis/prevención & control , Niño , Estudios Transversales , Heces/parasitología , Femenino , Humanos , Malasia/epidemiología , Masculino , Prevalencia , Factores de Riesgo , Salud Rural , Población Rural , Salud Urbana , Población Urbana
2.
Parasitol Int ; 65(6 Pt B): 797-801, 2016 Dec.
Artículo en Inglés | MEDLINE | ID: mdl-26780545

RESUMEN

Blastocystis (initially named as Blastocystis hominis) has long been known as a protist without any clinical significance. However, there is now a huge pile of case reports where Blastocystis is blamed for the symptoms and the infection described in the patients. Introduction of the presence of as many as 17 Blastocystis subtypes while many infected individuals are non-symptomatic initially brought about the correlation between the subtypes and pathogenicity; however, the outcomes of these trials were not consistent and did not explain its pathogenicity. Today, it is mostly acknowledged that Blastocystis may colonize many individuals but the infection's onset depends on the interaction between the virulence of parasites and host's immune competence. Eradication of Blastocystis is essential in some cases where it is the only infectious agent and patient is suffering from some symptoms. In such cases, metronidazole is the drug of choice but its efficacy is relatively low in some cases. Other agents used include trimethoprim-sulfamethoxazole, paromomycin, and furazolidone. Recent studies on the interactions between human health and the role of gut microbiota introduces new data which may significantly change our point of view against some protists, which we tend to see as "parasites requiring urgent eradication for cure". May the presence or absence of some Blastocystis subtypes necessary for human health, or is the absence or presence of certain Blastocystis subtypes in human gut is associated with certain diseases/infections? The answers of these questions will surely guide us to select patients requiring treatment against Blastocystis infection in future.


Asunto(s)
Antiparasitarios/uso terapéutico , Infecciones por Blastocystis/tratamiento farmacológico , Infecciones por Blastocystis/prevención & control , Blastocystis/fisiología , Erradicación de la Enfermedad , Antiparasitarios/farmacología , Blastocystis/efectos de los fármacos , Blastocystis/inmunología , Infecciones por Blastocystis/patología , Resistencia a Medicamentos , Humanos
3.
Am J Trop Med Hyg ; 93(2): 310-5, 2015 Aug.
Artículo en Inglés | MEDLINE | ID: mdl-26033017

RESUMEN

In September 2009, a cross-sectional study was conducted to evaluate parasitic infections in a child care center in Khlong Toei, Bangkok, Thailand. Of 503 children and staff members, 258 (51.3%) stool samples and questionnaires were obtained. The most common parasitic infection was Blastocystis sp. (13.6%). Blastocystis sp. subtype 3 was predominantly found (80.0%), followed by subtypes 2 (12.0%) and 1 (8.0%). The prevalence of Blastocystis infection varied among different age groups. The prevalence of Blastocystis infection in non-HIV-infected children aged < 10 and 10-19 years were 14.5% and 10.3%, respectively, which were not significantly different. All 31 HIV-infected children were not infected with Blastocystis sp. The most likely reason could be the result of properly using prevention measures for this specific group.


Asunto(s)
Infecciones por Blastocystis/epidemiología , Infecciones por Blastocystis/prevención & control , Cuidadores , Guarderías Infantiles , Adolescente , Adulto , Niño , Estudios Transversales , ADN Protozoario/aislamiento & purificación , Heces/parasitología , Femenino , Infecciones por VIH/epidemiología , Humanos , Masculino , Persona de Mediana Edad , Prevalencia , ARN Ribosómico 18S/aislamiento & purificación , Factores de Riesgo , Análisis de Secuencia de ADN , Factores Socioeconómicos , Manejo de Especímenes , Encuestas y Cuestionarios , Tailandia/epidemiología , Adulto Joven
4.
Parasit Vectors ; 5: 37, 2012 Feb 14.
Artículo en Inglés | MEDLINE | ID: mdl-22330427

RESUMEN

BACKGROUND: Blastocystis sp. is one of the most common intestinal protozoa in humans. Unlike other intestinal parasitic infections such as giardiasis and cryptosporidiosis, the epidemiology of blastocystosis in children who live in crowded settings such as day-care centers and orphanages has been rarely explored. METHODS: A retrospective cohort study was conducted to evaluate incidence and risk factors of Blastocystis infection in an orphanage every two consecutive months during April 2003 to April 2004, in Bangkok, Thailand. Blastocystis sp. was identified using direct simple smear, and in vitro cultivation in Jones' medium. RESULTS: The incidence rate was 1.8/100 person-months and the independent risk factors associated with Blastocystis infection were age, nutritional status and orphans living in the room where their childcare workers were infected. CONCLUSIONS: Person-to-person transmission was most likely to occur either from orphans to childcare workers or from childcare workers to orphans living in the same room. Universal precautions such as regular hand washing and careful handling of fecally contaminated materials are indicated.


Asunto(s)
Infecciones por Blastocystis/epidemiología , Blastocystis/aislamiento & purificación , Adulto , Infecciones por Blastocystis/prevención & control , Infecciones por Blastocystis/transmisión , Niño , Cuidado del Niño , Niños Huérfanos , Preescolar , Estudios de Cohortes , Heces/parasitología , Femenino , Humanos , Incidencia , Lactante , Recién Nacido , Masculino , Persona de Mediana Edad , Orfanatos , Estudios Retrospectivos , Factores de Riesgo , Encuestas y Cuestionarios , Tailandia/epidemiología , Adulto Joven
5.
J Egypt Soc Parasitol ; 38(1): 103-14, 2008 Apr.
Artículo en Inglés | MEDLINE | ID: mdl-19143124

RESUMEN

The effect of exogenous administration of antioxidant (Anttox) on the course of B. hominis in experimentally infected mice was studied. B. hominis isolates were obtained from 10 gastrointestinal symptomatic adult patients. Three groups of 30 infected mice (3/isolate) were used. GI was untreated infected, GII was treated by antox for 4 weeks after infection diagnosis (treatment strategy), and GIII antox treated by for 4 weeks before infection (prophylactic strategy). Mild pathological changes were detected on 13.4%, 19.9% & 86.8% of mice in Gs I, II & III, respectively. Moderate pathological changes were found in 29.9%, 26.6% & 6.6% of mice in Gs I, II & III, respectively. While, the majority of severe pathological changes were in Gs I & II (56.7% & 53.5%) as compared to GIII (6.6%). Meanwhile, 86.8% of mice in GIII had B. hominis forms > 10/high power field compared to 3.3% in Gs I & II, respectively. Although 19.8% of mice in GII were positive for B. hominis by direct smear, no growth resulted in vitro and all the forms were non-viable by using neutral red stain. All the differences were statistically significant. So, antioxidant exacerbated B. hominis intensity but it decreased the pathological changes.


Asunto(s)
Antioxidantes/farmacología , Antiprotozoarios/farmacología , Infecciones por Blastocystis/tratamiento farmacológico , Infecciones por Blastocystis/prevención & control , Blastocystis hominis/efectos de los fármacos , Animales , Antioxidantes/uso terapéutico , Antiprotozoarios/uso terapéutico , Infecciones por Blastocystis/patología , Tracto Gastrointestinal/parasitología , Humanos , Ratones , Índice de Severidad de la Enfermedad , Resultado del Tratamiento
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA